Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: A multicenter study

Circulation

Volumn 113, Issue 20, 2006, Pages 2391-2397

  Khairy, Paul ^a,b   Landzberg, Michael J ^b   Gatzoulis, Michael A ^c   Mercier, Lise Andrée ^a   Fernandes, Susan M ^b   Côté, Jean Marc ^d   Lavoie, Jean Pierre ^a   Fournier, Anne ^c,e   Guerra, Peter G ^c   Frogoudaki, Alexandra ^c,e   Walsh, Edward P ^b   Dore, Annie ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Heart defects, congenital; Implantable cardioverter defibrillators; Pacemakers; Shunts; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGE; AORTOPULMONARY SEPTAL DEFECT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; EBSTEIN ANOMALY; ENDOCARDIAL CUSHION DEFECT; FALLOT TETRALOGY; FEMALE; FOLLOW UP; GREAT VESSELS TRANSPOSITION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM SEPTUM DEFECT; HEART PACING; HEART RIGHT LEFT SHUNT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE ATRESIA; MULTICENTER STUDY; OXYGEN SATURATION; PACEMAKER; PHLEBOTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC DISEASE; THROMBOEMBOLISM; TRICUSPID VALVE ATRESIA; ARTERIOVENOUS SHUNT; ARTIFICIAL HEART PACEMAKER; CLASSIFICATION; CONGENITAL HEART MALFORMATION; INCIDENCE; METHODOLOGY; PEROPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL;

ARTERIOVENOUS SHUNT, SURGICAL; CARDIAC PACING, ARTIFICIAL; COHORT STUDIES; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; PACEMAKER, ARTIFICIAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 33744480532     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.622076     Document Type: Article

References (40)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-1900.
2. Rao PS. Transcatheter management of cyanotic congenital heart defects: a review. Clin Cardiol. 1992;15:483-496.
3. Yoshimura N, Yamaguchi M, Ohashi H, Oshima Y, Toyoda Y, Ogawa K. Classic Blalock-Taussig shunt in neonates. J Cardiovasc Surg (Torino). 1999;40:107-110.
4. Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy: a palliative approach to complete transposition of the great arteries. JAMA. 1966;196:991-992.
5. Khairy P, Landzberg MJ, Lambert J, O'Donnell CP. Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures. Cardiol Young. 2004;14:284-292.
6. Kanter RJ, Garson A Jr. Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease. Pacing Clin Electrophysiol. 1997;20(pt 2):502-511.
7. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marçon F, Alexander ME, Walsh EP. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation. 2004;109:1994-2000.
8. Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F, Colman JM, Oeschlin E, Taylor D, Perloff J, Somerville J, Webb GD. CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease, part I. Can J Cardiol. 2001;17:940-959.
9. Goff DA, Blume ED, Gauvreau K, Mayer JE, Lock JE, Jenkins KJ. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation. 2000;102:2094-2099.
10. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation. 1993;87:1954-1959.
11. Noiseux N, Khairy P, Fournier A, Vobecky SJ. Thirty years of experience with epicardial pacing ill children. Cardiol Young. 2004;14:512-519.
12. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG. Transient ischemic attack - proposal for a new definition. N Engl J Med. 2002;347:1713-1716.
13. Sachweh JS, Vazquez-Jimenez JF, Schondube FA, Daebritz SH, Dorge H, Muhler EG, Messmer BJ. Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg. 2000;17:455-461.
14. Gammage MD. Pacing approaches to the patient with a univentricular heart and the factors associated with choice of pacing site. Pacing Clin Electrophysiol. 2000;23:144.
15. Silka MJ, Rice MJ. Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol. 1991;14(pt 1):499-503.
16. Johnson C, Galindez L. Multiple systemic emboli complicating the course of a patient with an atrial septal defect, an atrial septal aneurysm and an endocardial right atrial pacemaker lead. P R Health Sci J. 1998;17:281-284.
17. Coleman DB, DeBarr DM, Morales DL, Spotnitz HM. Pacemaker lead thrombosis treated with atrial thrombectomy and biventricular pacemaker and defibrillator insertion. Ann Thorac Surg. 2004;78:e83-e84.
18. Barakat K, Robinson NM, Spurrell RA. Transvenous pacing lead-induced thrombosis: a series of cases with a review of the literature. Cardiology. 2000;93:142-148.
19. Karavidas A, Lazaros G, Matsakas E, Kouvousis N, Samara C, Christoforatou E, Zacharoulis A. Early pacemaker lead thrombosis leading to massive pulmonary embolism. Echocardiography. 2004;21:429-432.
20. Perry RA, Clarke DB, Shiu MF. Entanglement of embolised thrombus with an endocardial lead causing pacemaker malfunction and subsequent pulmonary embolism. Br Heart J. 1987;57:292-295.
21. Laury P, Chabert JP, Blaise C, Perotin S, Brasselet C, Schlick C, Tassan-Mangina S, Metz D, Elaerts J. A rare cause of stroke in a patient with a cardiac pacemaker. Arch Mal Coeur Vaiss. 2002;95:219-222.
22. Adnan Aslam A, McIlwain EF, Talano JV, Ferguson TB, McKinnie J, Kerut EK. An unusual case of embolic stroke: a permanent ventricular pacemaker lead entirely within the arterial system documented by transthoracic and transesophageal echocardiography. Echocardiography. 1999;16:373-378.
23. Territo MC, Rosove MH. Cyanotic congenital heart disease: hematologic management. J Am Coll Cardiol. 1991;18:320-322.
24. 2 and prostacyclin in children with cyanotic congenital heart disease. Br Heart J. 1993;69:179-182.
25. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol. 1996;28:768-772.
26. Gatzoulis MA, Walters J, McLaughlin PR, Merchant N, Webb GD, Liu P. Late arrhythmia in adults with the Mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? Heart. 2000;84:409-415.
27. Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation: risk marker for stroke. N Engl J Med. 1990;323:1556-1558.
28. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340:839-846.
29. Thorne SA. Management of polycythaemia in adults with cyanotic congenital heart disease. Heart. 1998;79:315-316.
30. Hartfield DS, Lowry NJ, Keene DL, Yager JY. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol. 1997;16:50-53.
31. Beder SD, Kuehl KS, Hopkins RA, Tonder LM, Mans DR. Precipitous exit block with epicardial steroid-eluting leads. Pacing Clin Electrophysiol. 1997;20(pt 1):2954-2957.
32. Walker F, Siu SC, Woods S, Cameron DA, Webb GD, Harris L. Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol. 2004;43:1894-1901.
33. Beaufort-Krol GC, Mulder H, Nagelkerke D, Waterbolk TW, Bink-Boelkens MT. Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus conventional endocardial pacing leads in children. J Thorac Cardiovasc Surg. 1999;117:523-528.
34. Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150-159.
35. Van Gelder BM, Bracke FA, Oto A, Yildirir A, Haas PC, Seger JJ, Stainback RF, Botman KJ, Meijer A. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multicenter experience and review of the literature. Pacing Clin Electrophysiol. 2000;23:877-883.
36. Ha JW, Shin MS, Kang S, Pyun WB, Jang KJ, Byun KH, Rim SJ, Huh J, Lee BI, Chung N. Enhanced detection of right-to-left shunt through patent foramen ovale by transthoracic contrast echocardiography using harmonic imaging. Am J Cardiol. 2001;87:669-671.
37. Child JS. Echo-Doppler and color-flow imaging in congenital heart disease. Cardiol Clin. 1990;8:289-313.
38. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139:753-760.
39. Landzberg MJ, Khairy P. Indications for the closure of patent foramen ovale. Heart. 2004;90:219-224.
40. Jimenez RM, Martin F, Diego M, Santos JL, Arribas A, Martin Luengo C. Hypoxemia and stroke in a patient with a pacemaker. Rev Esp Cardiol. 2004;57:265-267.